Michael Török

1.6k total citations
24 papers, 1.3k citations indexed

About

Michael Török is a scholar working on Molecular Biology, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Michael Török has authored 24 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Michael Török's work include Drug Transport and Resistance Mechanisms (7 papers), Mitochondrial Function and Pathology (5 papers) and Metabolism and Genetic Disorders (5 papers). Michael Török is often cited by papers focused on Drug Transport and Resistance Mechanisms (7 papers), Mitochondrial Function and Pathology (5 papers) and Metabolism and Genetic Disorders (5 papers). Michael Török collaborates with scholars based in Switzerland, Germany and Chile. Michael Török's co-authors include Jürgen Drewe, Stephan Krähenbühl, Gert Fricker, Priska Kaufmann, Heike Gutmann, Karin Brecht, Jörg Huwyler, Christoph Beglinger, Anja Zahno and K. Waldhauser and has published in prestigious journals such as The Lancet, Hepatology and Biochemical Journal.

In The Last Decade

Michael Török

23 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Török Switzerland 16 483 418 291 235 231 24 1.3k
P.M. Mrozikiewicz Poland 22 666 1.4× 403 1.0× 498 1.7× 271 1.2× 135 0.6× 128 1.8k
Azza A. K. El‐Sheikh Egypt 22 447 0.9× 412 1.0× 261 0.9× 274 1.2× 139 0.6× 77 1.8k
KM Giacomini United States 17 512 1.1× 715 1.7× 323 1.1× 400 1.7× 252 1.1× 28 1.5k
Yong–Hae Han United States 19 378 0.8× 584 1.4× 295 1.0× 307 1.3× 68 0.3× 39 1.3k
Ajai K. Chaudhary United States 23 781 1.6× 624 1.5× 309 1.1× 287 1.2× 107 0.5× 27 2.0k
Alison E.M. Vickers United States 23 443 0.9× 330 0.8× 503 1.7× 138 0.6× 197 0.9× 55 1.5k
Hidetaka Kamimura Japan 24 423 0.9× 676 1.6× 651 2.2× 255 1.1× 101 0.4× 98 1.6k
Toshinori Kamisako Japan 20 392 0.8× 604 1.4× 176 0.6× 438 1.9× 325 1.4× 63 1.3k
Joachim Grevel United States 24 347 0.7× 266 0.6× 150 0.5× 704 3.0× 450 1.9× 64 2.2k
Suparat Khamdang Japan 10 283 0.6× 749 1.8× 183 0.6× 388 1.7× 96 0.4× 12 1.4k

Countries citing papers authored by Michael Török

Since Specialization
Citations

This map shows the geographic impact of Michael Török's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Török with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Török more than expected).

Fields of papers citing papers by Michael Török

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Török. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Török. The network helps show where Michael Török may publish in the future.

Co-authorship network of co-authors of Michael Török

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Török. A scholar is included among the top collaborators of Michael Török based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Török. Michael Török is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Török, Michael, et al.. (2024). Translating a Culture of Quality to Clinical Research Conduct: Expanding the Clinical Development Quality Framework. Therapeutic Innovation & Regulatory Science. 58(3). 404–414.
2.
Nováková, Kateřina, Michael Török, Miljenko V. Panajatovic, et al.. (2022). PGC-1α and MEF2 Regulate the Transcription of the Carnitine Transporter OCTN2 Gene in C2C12 Cells and in Mouse Skeletal Muscle. International Journal of Molecular Sciences. 23(20). 12304–12304. 2 indexed citations
3.
Török, Michael, et al.. (2013). A cell-based, multiparametric sensor approach characterises drug-induced cytotoxicity in human liver HepG2 cells. Toxicology in Vitro. 27(3). 1109–1120. 12 indexed citations
4.
Zahno, Anja, et al.. (2010). The role of CYP3A4 in amiodarone-associated toxicity on HepG2 cells. Biochemical Pharmacology. 81(3). 432–441. 97 indexed citations
5.
Bur, Daniel, Hilary Brooks, Michael Török, et al.. (2008). Pharmacological manipulation of L-carnitine transport into L6 cells with stable overexpression of human OCTN2. Cellular and Molecular Life Sciences. 65(10). 1596–1608. 20 indexed citations
6.
Knapp, Andrea, et al.. (2008). Effect of Carnitine Deprivation on Carnitine Homeostasis and Energy Metabolism in Mice with Systemic Carnitine Deficiency. Annals of Nutrition and Metabolism. 52(2). 136–144. 13 indexed citations
7.
Török, Michael, et al.. (2007). Hepatic effects of Cimicifuga racemosa extract in vivo and in vitro. Cellular and Molecular Life Sciences. 64(21). 2848–2857. 32 indexed citations
8.
Török, Michael, et al.. (2007). Hepatocellular toxicity of kava leaf and root extracts. Phytomedicine. 15(1-2). 120–131. 24 indexed citations
9.
Kaufmann, Priska, Michael Török, Anja Zahno, et al.. (2006). Toxicity of statins on rat skeletal muscle mitochondria. Cellular and Molecular Life Sciences. 63(19-20). 2415–2425. 201 indexed citations
10.
Kaufmann, Priska, Manuel Haschke, Michael Török, et al.. (2006). Mechanisms of Venoocclusive Disease Resulting From the Combination of Cyclophosphamide and Roxithromycin. Therapeutic Drug Monitoring. 28(6). 766–774. 5 indexed citations
11.
Waldhauser, K., Michael Török, Daniel Konrad, et al.. (2006). Hepatocellular Toxicity and Pharmacological Effect of Amiodarone and Amiodarone Derivatives. Journal of Pharmacology and Experimental Therapeutics. 319(3). 1413–1423. 100 indexed citations
12.
Kaufmann, Priska, et al.. (2005). Mechanisms of benzarone and benzbromarone‐induced hepatic toxicity†. Hepatology. 41(4). 925–935. 150 indexed citations
13.
Kaufmann, Priska, et al.. (2004). 78 Mechanisms of benzarone and benzbromarone induced hepatic toxicity. Journal of Hepatology. 40. 27–28. 6 indexed citations
14.
Kaufmann, Priska, Konstantin Beier, Michael Török, et al.. (2003). Mechanisms of liver steatosis in rats with systemic carnitine deficiency due to treatment with trimethylhydraziniumpropionate. Journal of Lipid Research. 44(1). 144–153. 41 indexed citations
15.
Bogman, Katrijn, et al.. (2001). HMG‐CoA reductase inhibitors and P‐glycoprotein modulation. British Journal of Pharmacology. 132(6). 1183–1192. 162 indexed citations
16.
Török, Michael, Heike Gutmann, Gert Fricker, & Jürgen Drewe. (1999). Sister of P-glycoprotein expression in different tissues. Biochemical Pharmacology. 57(7). 833–835. 27 indexed citations
17.
Gutmann, Heike, et al.. (1999). Evidence for Different ABC-Transporters in Caco-2 Cells Modulating Drug Uptake. Pharmaceutical Research. 16(3). 402–407. 108 indexed citations
18.
Drewe, Jürgen, Heike Gutmann, Gert Fricker, et al.. (1999). HIV protease inhibitor ritonavir: a more potent inhibitor of P-glycoprotein than the cyclosporine analog SDZ PSC 833. Biochemical Pharmacology. 57(10). 1147–1152. 156 indexed citations
19.
Gutmann, Heike, Michael Török, Gert Fricker, et al.. (1999). Modulation of Multidrug Resistance Protein Expression in Porcine Brain Capillary Endothelial Cells In Vitro. Drug Metabolism and Disposition. 27(8). 937–941. 57 indexed citations
20.
Török, Michael, Jörg Huwyler, Jürgen Drewe, Heike Gutmann, & Gert Fricker. (1998). Transport of the beta-lactam antibiotic benzylpenicillin and the dipeptide glycylsarcosine by brain capillary endothelial cells in vitro.. PubMed. 26(11). 1144–8. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P.M. Mrozikiewicz Breakdown of academic impact, for papers by Azza A. K. El‐Sheikh Breakdown of academic impact, for papers by KM Giacomini Breakdown of academic impact, for papers by Yong–Hae Han Breakdown of academic impact, for papers by Ajai K. Chaudhary Breakdown of academic impact, for papers by Alison E.M. Vickers Breakdown of academic impact, for papers by Hidetaka Kamimura Breakdown of academic impact, for papers by Toshinori Kamisako Breakdown of academic impact, for papers by Joachim Grevel Breakdown of academic impact, for papers by Suparat Khamdang
Rankless by CCL
2026